BPC 157 is a peptide many people turn to for its potential health benefits, like helping muscles recover and reducing inflammation
So theres a good reason women in menopause might have weight (along with hot flashes, insomnia, and dozens of other symptoms of hormone change) on their minds
Bergamini S, Rota C, Canali R, Staffieri M, Daneri F, Bini A, Giovannini F, Tomasi A, Iannone A: N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase
Qualifying reasons under 503A include: Allergy to phenol or another preservative in the commercial formulation Need for a dose strength not commercially available (e.g., 1.5 mg, which falls between Ozempic's 1 mg and 2 mg pens) Inability to use the pen injector device due to dexterity issues (though this is weak because vial-and-syringe versions could theoretically be requested from Novo Nordisk) The FDA has historically taken a narrow view of what constitutes a legitimate patient-specific need, and "I prefer the compounded version" or "the commercial version is too expensive" do not qualify
Third-party verification provides an objective baseline for researchers to trust their experimental inputs
At Cape Fear Physical Medicine and Rehab, we recognize that each patients journey is unique
